Next Article in Journal
Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Next Article in Special Issue
Risk of Metabolic Syndrome in Kidney Stone Formers: A Comparative Cohort Study with a Median Follow-Up of 19 Years
Previous Article in Journal
Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis
Previous Article in Special Issue
Single-Site Sutureless Partial Nephrectomy for Small Exophytic Renal Tumors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Quality Assessment of CEUS in Individuals with Small Renal Masses—Which Individual Factors Are Associated with High Image Quality?

by
Paul Spiesecke
1,
Thomas Fischer
1,
Frank Friedersdorff
2,
Bernd Hamm
1 and
Markus Herbert Lerchbaumer
1,*
1
Department of Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
2
Department of Urology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(12), 4081; https://doi.org/10.3390/jcm9124081
Submission received: 17 November 2020 / Revised: 9 December 2020 / Accepted: 13 December 2020 / Published: 17 December 2020

Abstract

:
Obesity and bowel gas are known to impair image quality in abdominal ultrasound (US). The present study aims at identifying individual factors in B-mode US that influence contrast-enhanced US (CEUS) image quality to optimize further imaging workup of incidentally detected focal renal masses. We retrospectively analyzed renal CEUS of focal renal masses ≤ 4 cm performed at our center in 143 patients between 2016 and 2020. Patient and lesion characteristics were tested for their influence on focal and overall image quality assessed by two experienced radiologists using Likert scales. Effects of significant variables were quantified by receiver operating characteristics (ROC) curve analysis with area under the curve (AUC), and combined effects were assessed by binary logistic regression. Shrunken kidney, kidney depth, lesion depth, lesion size, and exophytic lesion growth were found to influence focal renal lesion image quality, and all factors except lesion size also influenced overall image quality. Combination of all parameters except kidney depth best predicted good CEUS image quality showing an AUC of 0.91 (p < 0.001, 95%-CI 0.863–0.958). The B-mode US parameters investigated can identify patients expected to have good CEUS image quality and thus help select the most suitable contrast-enhanced imaging strategy for workup of renal lesions.

1. Introduction

Renal lesions are estimated to occur in 13% to 27% of the general population [1,2,3]. Small renal masses (SRMs) defined as lesions ≤ 4 cm, tend to be asymptomatic and are often detected incidentally on imaging [4,5]. It is generally known that the incidence of malignancy increases with the size of a SRM [6]. Therefore, early and accurate diagnosis of small renal lesions is very important to plan further patient management and ensure good patient outcome.
Since the risk of malignancy in solid renal tumors is high with incidences of 87.2% and 83.9% reported by Frank et al. and Kutikov et al., respectively [7,8], the choice of a suitable imaging method for reliable differentiation of malignant from benign lesions is essential for the diagnostic process. Often, a renal tumor is detected as an incidental finding in a routine ultrasound (US) examination, and the question as to the most appropriate further imaging strategy arises. Although US has many advantages including the absence of ionizing radiation as well as low costs and high availability, a systematic review by Vogel et al. identified poor diagnostic performance of conventional US in renal tumors [9], making contrast-enhanced imaging necessary for a reliable characterization. In this review, Vogel et al. showed comparable sensitivity for contrast-enhanced computed tomography (ceCT), contrast-enhanced magnetic resonance imaging (ceMRI) and contrast-enhanced ultrasound (CEUS) [9]. Furthermore, CEUS turned out to have higher diagnostic accuracy than ceCT in the evaluation of complex cystic renal masses [9].
Besides diagnostic accuracy, the setting of a contrast-enhanced examination plays a decisive role: while ceCT still remains the first-line imaging modality for SRMs, MRI has become more widely used over the last decade and also avoids radiation exposure, but its general use is limited by its availability and cost [10]. On the other hand, CEUS is superior regarding the evaluation of microcirculation as it uses a strictly intravascular contrast agent consisting of gas-filled microbubbles [10].
For CEUS of focal liver lesions, it has been shown that diagnostic confidence is improved by good examination conditions [11]. The authors of this study defined difficult ultrasound (US) conditions as the presence of meteorism, distinct steatosis, liver cirrhosis with inhomogeneous tissue, and obesity with a body mass index (BMI) > 30 kg/m2 [11].
In 2018, Sidhu et al. published the EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology) guidelines and recommendations for the use of CEUS in non-hepatic applications [12]. Next to renal ischemia, they identify focal renal lesions as the main indication for CEUS in the kidney. The focal renal lesions that can be diagnosed using CEUS are pseudotumors, cystic, indeterminate and solid masses as well as renal infections [12]. Thus, indications for CEUS include the whole range of SRMs investigated here, and the question arises of which patient-related imaging factors must be met to allow a CEUS examination likely to yield sufficient image quality for correct diagnostic characterization. This should help in deciding, in each case, whether a patient would benefit more from CEUS or cross-sectional imaging after initial sonographic detection of a SRM.
To our knowledge, this is the first study systematically analyzing essential patient and lesion characteristics and their influence on CEUS image quality in renal US.

2. Materials and Methods

This retrospective study was registered with our institution’s ethics committee (EA1/320/20). The oral and written informed consent of all patients was obtained before the examination. All study data were collected in compliance with the principles expressed in the 2002 Declaration of Helsinki.

2.1. Study Population

A database query for CEUS examinations of focal renal lesions performed in our hospital’s interdisciplinary ultrasound center between January 2016 and May 2020 was conducted. The cases retrieved by this search were screened regarding the following inclusion criteria: (I) age ≥ 18 years, (II) CEUS examination of a focal renal lesion ≤ 4 cm, and (III) sufficient image data for quality assessment (stored cine loops and multiple images). Exclusion criteria were (I) autosomal-dominant polycystic kidney disease and (II) no lesion or other indication for CEUS (assessment of renal perfusion).

2.2. CEUS Examination

Gray-scale B-mode US of the kidney was performed for lesion detection and for assessment of kidney size, echogenicity, and homogeneity using high-end ultrasound systems with a 1–6 MHz convex array transducer (Aplio i500/i900, Canon Medical Systems Corporation, Tochigi, Japan; Acuson Sequoia, Siemens Healthineers, Erlangen, Germany). The kidney was routinely examined in modified longitudinal and transverse planes and, if necessary, in deep inspiration and with optimized scanning positions.
CEUS examinations were performed during clinical routine using high-end ultrasound systems with up-to-date CEUS-specific protocols available at the time of the examination. The examinations were performed at 1–6 MHz with convex array transducers. A bolus of 1.6 mL of ultrasound contrast agent (SonoVue®, Bracco Imaging, Milan, Italy) was administered in all patients, and a very low mechanical index (MI < 0.1) was used to avoid early microbubble destruction. Penetration depth on CEUS was adapted by the investigator to clearly identify the target lesion and whole kidney. Baseline B-mode US and CEUS (for qualitative assessment of contrast enhancement pattern) were performed by a single highly experienced radiologist with more than ten years of experience in CEUS (EFSUMB level 3).
The associated data concerning the included patients were reviewed to collect individual information. The Radiology Information System (RIS) was used to cover age and gender.

2.3. Assessment of Image Quality

Image quality was evaluated by two radiologists in consensus, one of them an EFSUMB level 3 examiner and both experienced in the field of renal CEUS. One factor assessed was presence of reduced parenchymal thickness or shrunken kidney (renal atrophy). Kidney depth and lesion depth were determined as the shortest distance of the renal capsule/superficial part of the lesion to the probe. Cases were stratified by lesion size and localization in the left versus right kidney and site within the kidney—upper third, middle or lower third—on representative CEUS loops, if not described in the diagnostic reports. Image quality at the target site (lesion) and overall image quality (kidney) were assessed in terms of diagnostic confidence by two experienced readers using an ordinal scoring system (Likert scale): 1—insufficient quality, 2—poor quality, 3—adequate quality, 4—good quality, 5—excellent quality. Representative examples of CEUS images illustrating different image qualities are shown in Figure 1.

2.4. Statistical Analysis

Continuous variables are reported as median and interquartile range (IQR) and categorical variables as absolute/total numbers (n/N) and percentages in brackets. The aim of our analysis is to identify patient and lesion factors that affect CEUS image quality. Therefore, image quality scores—ordinally scaled—were correlated with the presence of various patient- and lesion-related variables using the Chi2 test for variables measured in ratio scale and the Kruskal-Wallis test for ordinally scaled variables. Effects were analyzed for both focal (site of renal lesion) and overall image quality. In addition, a univariate ANOVA was performed to detect possible uncertainties. Moreover, post hoc testing with Bonferroni correction was done to ensure that at least two image quality groups differed statistically significantly from each other. To investigate the interdependence of impact of lesion location (right vs. left kidney and kidney third) on image quality, a two-factorial ANOVA of these two factors was performed.
For the parameters identified to have a statistically significant influence on image quality, the effect was quantified by receiver operating characteristics (ROC) curve analysis with quantification of the area under the curve (AUC). Therefore, good image quality was defined as a score of 4 or 5 on the Likert scale as described above. Furthermore, different combinations of individual parameters with a statistically significant influence on image quality were tested by binary logistic regression to determine the AUCs quantifying the influence of the combined parameters. The best combination of individual parameters was identified as the combination with the largest AUC and the smallest number of included parameters compared to other combinations with the same AUC.
A two-sided significance level of α = 0.05 was considered appropriate to indicate statistical significance. All statistical analyses were performed using the SPSS software (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. IBM Corp: Armonk, NY, USA.).

3. Results

3.1. Study Population

The final study population included 143 patients with at least one renal target lesion ≤ 4 cm and sufficient stored image data for quality assessment. The patients’ baseline characteristics are presented in Table 1. Ninety-four of the initially identified CEUS examinations were excluded since they were repeat follow-up examinations of already included patients. The study patients had a median age of 62 years (IQR, 52–75 years). Cystic renal lesions were found in 78.3% of the cases and 21.7% as solid renal lesions. Overall mean lesion depth was 61 mm (IQR, 46–74 mm).
Presented are the baseline characteristics of the study population subdivided into patient- and lesion-related features. Continuous variables are given as median (IQR), categorical variables as absolute/total numbers (n/N) and percentages in brackets.

3.2. Assessment of Image Quality

Arithmetic means of image quality scores were 3.7 and 3.6 for focal and overall image quality, respectively. Focal image quality scores 1–5 were distributed as follows: 4 (2.8%), 15 (10.5%), 43 (30.1%), 42 (29.4%), and 39 (27.3%). For overall image quality, score distribution was: 6 (4.2%), 22 (15.4%), 39 (27.3%), 28 (19.6%), and 48 (33.6%). Correlation with individual patient and lesion characteristics yielded the following results: there were no strong correlations between imaging quality and age, sex, reduced cortical thickness or entity, localization, and size of lesion (Table 2). A statistically significant increase in image quality was found for (I) exophytic growth of focal renal lesion, (II) absence of shrunken kidneys, (III) lower lesion depth, and (IV) lower depth of lesion-bearing kidney (Table 2, Figure 2). For intrarenal lesion site (upper, middle, lower third), the Chi2 test yielded no correlation with image quality (p = 0.064), whereas ANOVA reached significance (p = 0.040). With the restrictive approach used here, we do not interpret the results as showing a strong correlation in order to satisfy the discrepancy between the two applied statistical tests.
Table 2 presents the results of the statistical tests investigating effects on focal and overall image quality. For each variable and both focal and overall image quality, a nonparametric test and an ANOVA were performed to account for possible uncertainties.
The two-sided ANOVA confirmed the results given in Table 2, showing both focal lesion quality (p = 0.155) and overall quality (p = 0.127) not to be impacted by the combined lesion location parameters (right/left kidney and intrarenal lesion site).

3.3. Post Hoc Tests

The results of post hoc ANOVA confirmed that sex, age, lesion type, shrunken kidney, and side of involved kidney had no statistically significant impact on focal or overall image quality. Additionally, intrarenal lesion localization (third) was shown to have no statistically significant effect on focal or overall image quality, whereas univariate ANOVA of focal lesion quality identified an effect of intrarenal lesion localization (p = 0.046), which was confirmed by the Chi2 test (p = 0.064). As expected from univariate ANOVA, testing with Bonferroni correction also identified no statistically significant effect of lesion size on overall image quality.
For both focal and overall image quality, statistically significant (p ≤ 0.05) differences between at least two groups were found in groupwise comparisons of image quality performed with Bonferroni correction for the following parameters: shrunken kidney, kidney depth, lesion depth, and exophytic lesion growth. For lesion size, a statistically significant difference between at least two groups was found only for the effect on focal image quality.

3.4. ROC Analysis

ROC analysis was performed to quantify the characteristic’s influence on reaching high image quality (≥4 Likert scores). The results of ROC curve analysis with the area under the curve (AUC) for continuous and categorial variables are presented in Table 3 and in Figure 3.
ROC analysis was performed to quantify effects of statistically significant variables influencing image quality (Table 2). The ROC curves of all variables showed statistical significance. Nevertheless, the asymptotic 95%-CI of exophytic lesion growth strikes 0.5 in overall image quality and was therefore not considered in further evaluation.
Presented are receiver operating characteristics (ROC) curves of individual parameters and the best combination, as presented in Table 4, influencing focal image quality (Likert score of 4 as cut-off). Diagonal segments were produced by ties.
AUC revealed lesion depth to be associated with focal image quality and kidney depth to be the strongest predictor of overall image quality, confirming the theoretical expectation regarding image quality assessment.

3.5. Combined ROC Analysis

As described in the Methods section, the combination of shrunken kidney, lesion depth, lesion size, and exophytic lesion growth were identified to be the most suitable combination of parameters (Table 4) showing strong correlation with good focal image quality (score of 4 or 5). with an effect size of an AUC of 0.91 (asymptotic 95%-CI: 0.863–0.958) and asymptotic statistical significance of p < 0.001.

4. Discussion

The major results of the present study can be summarized as follows: (I) CEUS image quality is reduced in shrunken kidneys and improved when examining exophytically growing lesions, and with shorter distance of the kidney and the lesion from the transducer; this applies to both focal and overall image quality; (II) focal, but not overall, image quality increases with lesion size, while patient age and sex, lesion entity, reduced parenchymal thickness and lesion localization do not impact CEUS image quality; and (III) the significant parameters just mentioned above improve focal image quality more markedly than the individual parameters alone, with the combination of shrunken kidney, lesion depth, lesion size, and exophytic lesion growth proving to be the most suitable combination.
Putz et al. reported meteorism and obesity as the main patient-related factors with a negative effect on CEUS image quality [11]. While CEUS is predominantly used for liver imaging, renal applications of CEUS have attracted growing interest. Therefore, an interest exists in knowing which patient factors might reliably predict a sufficient CEUS image quality. This is the rationale for our study, which—to our knowledge—is the first systematic analysis of individual patient- and lesion-related factors that have an effect on the image quality of renal CEUS.
Nevertheless, it must be mentioned that not only patient and lesion characteristics influence image quality, and therefore diagnostic accuracy, but also artifacts which are partially CEUS-specific, such as near-field signal loss due to microbubble destruction—which can be influenced by using a specific configuration of the US machine [13,14].
Our results have important implications for the diagnostic workup of SRMs detected on nonenhanced imaging: CEUS shows high diagnostic performance [9] and other advantages including a low rate of side effects [15]. Therefore, CEUS is generally preferred for the characterization of focal renal lesion. A recently published study showed CEUS, even in a small cohort of six pregnant women, to be a safe imaging tool [16]. Knowing beforehand whether a chosen imaging modality is likely to yield a diagnosis can shorten the diagnostic process, improving patient comfort and outcome. Using CEUS only where it is expected to achieve diagnostic quality, its instantaneous diagnosis determines directly if cross-sectional imaging is necessary for cancer staging if a malignant lesion is diagnosed, thus preventing unnecessary imaging in patients with benign lesions.
The prediction as to whether CEUS or MRI might be the better imaging method for further characterization of an SRM incidentally detected by plain B-mode ultrasound also has important economic implications, identifying patients not in need of undergoing MRI.
CEUS benefits—especially shown for renal cysts—from a higher temporal resolution than CT and MRI, allowing real-time evaluation of the enhancement pattern [17,18,19].
Therefore, immediate workup of an incidental SRM by CEUS in suitable patients can save costs by replacing cross-sectional MRI. Besides, the MRI and CT slots not needed for patients worked up by CEUS can help other patients to obtain their MRI or CT examination more quickly.
Apart from what has been discussed so far, patient preferences should also play a role in selecting an imaging modality. For example, Thorpe et al. found that more than 50% of individuals have a high grade of anxiety during an MRI examination, which could, for instance, promote the occurrence of motion artifacts [20]. Another concern with ceMRI is that gadolinium deposition in the brain has been observed in patients undergoing repeated MRI with administration of a gadolinium-based contrast agent—although its pathologic value is unclear [21,22]. Nevertheless, clinically relevant side effects of iodinated contrast agents used in ceCT are more common: “contrast-induced nephropathy” or “postcontrast acute kidney injury” has an incidence between 5.0% and 6.4% based on meta-analysis data [23,24,25]. Not being limited by adverse effects such as nephrotoxicity, cumulative radiation exposure or gadolinium deposition, CEUS is well suited for long-term surveillance, for instance, in patients with Bosniak IIF cysts [26].
Besides the image quality expectable in CEUS examination, it must be mentioned that patients with shrunken kidneys might not provide a high image quality, but would suffer from iodinated contrast agents in ceCT, since impaired renal function was found to be associated with contrast-induced nephropathy [24]. Although, as mentioned above, its clinical relevance is subject to controversial discussions, impaired renal function also leads to a reduced elimination of Gadolinium-containing contrast agents used in ceMRI [27]. So an expected low image quality could be relativized by potential harm using the alternative of contrast-enhanced imaging.
Experienced examiners are able to estimate CEUS image quality from B-mode image quality. Nevertheless, our results can help less experienced examiners and allow an objective assessment of expected CEUS image quality in inconclusive cases. Moreover, our approach is straightforward, using criteria that are rapidly assessed such as lesion depth or exophytic lesion growth. Although the two variables show comparable results in our study, lesion depth should be preferred to kidney depth, since this information is also important for lesion characterization rather than for assessing obesity only. Finally, the parameters presented here should be considered together, since the AUC for individual parameters alone are not larger than 0.8 (Table 3). Obviously, an experienced examiner can also characterize SRMs with a lower image quality, but we used high-end US-devices in our study and acquisition of CEUS-loops by an experienced radiologist and vindicate, therefore, our ROC analyses (Table 3 and Table 4, Figure 3) with an image quality score of four as cut-off.

4.1. Limitations

Our study is limited by its retrospective and single-center design. Nevertheless, all patients were examined with an identical CEUS protocol. All ultrasound examinations were performed using high-end systems with state-of-the-art CEUS-specific protocols, resulting in generally high image quality. Nevertheless, we compared CEUS loops obtained with a standardized protocol to assess image quality and imaging parameters, and not the image quality of the system as such.

4.2. Conclusions

Focal image quality of CEUS examinations is impaired by shrunken kidney, a large distance of the kidney and lesion from the body surface, and smaller lesion size, while exophytic growth of a focal renal lesion results in better image quality. Awareness of patient and lesion factors that degrade image quality can be used for better patient selection and can thus improve diagnostic confidence of examiners performing CEUS.

Author Contributions

Conceptualization, P.S. and M.H.L.; Formal analysis, P.S., T.F. and M.H.L.; Writing—original draft, P.S. and M.H.L.; Writing—review & editing, P.S., T.F., F.F., B.H. and M.H.L. All authors revised the manuscript critically for important intellectual content and gave final approval of the submitted manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité-Universitätsmedizin Berlin.

Acknowledgments

The authors thank Bettina Herwig for language editing of the manuscript.

Conflicts of Interest

None of the authors reports a relationship with industry and other relevant entities—financial or otherwise—that might pose a conflict of interest in connection with the submitted article. The following authors report financial activities outside the submitted work: Paul Spiesecke reports no conflict of interest. Thomas Fischer reports having received consultancy honoraria from Bracco and Canon Medical Imaging. Frank Friedersdorff reports no conflict of interest. Bernd Hamm reports having received consultancy honoraria from Canon Medical Imaging. Markus H. Lerchbaumer reports having received consultancy honoraria from Siemens Healthineers.

Abbreviations

ANOVAanalysis of variance
AUCarea under the curve
BMIbody mass index
CEUScontrast-enhanced ultrasound
ceCTcontrast-enhanced computed tomography
ceMRIcontrast-enhanced magnetic resonance imaging
CIconfidence interval
IQR interquartile range
ROCreceiver operating characteristics
SRMsmall renal mass
USultrasound

References

  1. Gill, I.S.; Aron, M.; Gervais, D.A.; Jewett, M.A.S. Clinical practice. Small renal mass. N. Engl. J. Med. 2010, 362, 624–634. [Google Scholar] [CrossRef]
  2. Hara, A.K.; Johnson, C.D.; MacCarty, R.L.; Welch, T.J. Incidental extracolonic findings at CT colonography. Radiology 2000, 215, 353–357. [Google Scholar] [CrossRef] [Green Version]
  3. Tada, S.; Yamagishi, J.; Kobayashi, H.; Hata, Y.; Kobari, T. The incidence of simple renal cyst by computed tomography. Clin. Radiol. 1983, 34, 437–439. [Google Scholar] [CrossRef]
  4. Turner, R.M., 2nd; Morgan, T.M.; Jacobs, B.L. Epidemiology of the Small Renal Mass and the Treatment Disconnect Phenomenon. Urol. Clin. N. Am. 2017, 44, 147–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Hollingsworth, J.M.; Miller, D.C.; Daignault, S.; Hollenbeck, B.K. Rising incidence of small renal masses: A need to reassess treatment effect. J. Natl. Cancer Inst. 2006, 98, 1331–1334. [Google Scholar] [CrossRef] [PubMed]
  6. Patel, H.D.; Semerjian, A.; Gupta, M.; Pavlovich, C.P.; Johnson, M.H.; Gorin, M.A.; Allaf, M.E.; Pierorazio, P.M. Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literature. Urol. Oncol. 2019, 37, 519–524. [Google Scholar] [CrossRef] [PubMed]
  7. Kutikov, A.; Fossett, L.K.; Ramchandani, P.; Tomaszewski, J.E.; Siegelman, E.S.; Banner, M.P.; Van Arsdalen, K.N.; Wein, A.J.; Malkowicz, S.B. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 2006, 68, 737–740. [Google Scholar] [CrossRef] [PubMed]
  8. Frank, I.; Blute, M.L.; Cheville, J.C.; Lohse, C.M.; Weaver, A.L.; Zincke, H. Solid renal tumors: An analysis of pathological features related to tumor size. J. Urol. 2003, 170, 2217–2220. [Google Scholar] [CrossRef]
  9. Vogel, C.; Ziegelmuller, B.; Ljungberg, B.; Bensalah, K.; Bex, A.; Canfield, S.; Giles, R.H.; Hora, M.; Kuczyk, M.A.; Merseburger, A.S.; et al. Imaging in Suspected Renal-Cell Carcinoma: Systematic Review. Clin. Genitourin. Cancer 2019, 17, e345–e355. [Google Scholar] [CrossRef]
  10. Rossi, S.H.; Prezzi, D.; Kelly-Morland, C.; Goh, V. Imaging for the diagnosis and response assessment of renal tumours. World J. Urol. 2018, 36, 1927–1942. [Google Scholar] [CrossRef] [Green Version]
  11. Putz, F.J.; Verloh, N.; Erlmeier, A.; Schelker, R.C.; Schreyer, A.G.; Hautmann, M.G.; Stroszczynski, C.; Banas, B.; Jung, E.M. Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions. Clin. Hemorheol. Microcirc. 2019, 71, 267–276. [Google Scholar] [CrossRef] [PubMed]
  12. Sidhu, P.S.; Cantisani, V.; Dietrich, C.F.; Gilja, O.H.; Saftoiu, A.; Bartels, E.; Bertolotto, M.; Calliada, F.; Clevert, D.-A.D.-A.; Cosgrove, D.; et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018, 39, e2–e44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Fetzer, D.T.; Rafailidis, V.; Peterson, C.; Grant, E.G.; Sidhu, P.; Barr, R.G. Artifacts in contrast-enhanced ultrasound: A pictorial essay. Abdom. Radiol. 2018, 43, 977–997. [Google Scholar] [CrossRef] [PubMed]
  14. Dietrich, C.F.; Ignee, A.; Greis, C.; Cui, X.W.; Schreiber-Dietrich, D.G.; Hocke, M. Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. Ultraschall Med. 2014, 35, 107–108. [Google Scholar] [CrossRef] [PubMed]
  15. Piscaglia, F.; Bolondi, L. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med. Biol. 2006, 32, 1369–1375. [Google Scholar] [CrossRef]
  16. Schwarze, V.; Marschner, C.; Negrão de Figueiredo, G.; Rübenthaler, J.; Clevert, D.-A. Single-Center Study: Evaluating the Diagnostic Performance and Safety of Contrast-Enhanced Ultrasound (CEUS) in Pregnant Women to Assess Hepatic Lesions. Ultraschall Med. 2020, 41, 29–35. [Google Scholar] [CrossRef]
  17. Olson, M.C.; Abel, E.J.; Mankowski Gettle, L. Contrast-Enhanced Ultrasound in Renal Imaging and Intervention. Curr. Urol. Rep. 2019, 20, 73. [Google Scholar] [CrossRef]
  18. Harvey, C.J.; Alsafi, A.; Kuzmich, S.; Ngo, A.; Papadopoulou, I.; Lakhani, A.; Berkowitz, Y.; Moser, S.; Sidhu, P.S.; Cosgrove, D.O. Role of US Contrast Agents in the Assessment of Indeterminate Solid and Cystic Lesions in Native and Transplant Kidneys. Radiographics 2015, 35, 1419–1430. [Google Scholar] [CrossRef]
  19. Park, B.K.; Kim, B.; Kim, S.H.; Ko, K.; Lee, H.M.; Choi, H.Y. Assessment of cystic renal masses based on Bosniak classification: Comparison of CT and contrast-enhanced US. Eur. J. Radiol. 2007, 61, 310–314. [Google Scholar] [CrossRef]
  20. Thorpe, S.; Salkovskis, P.M.; Dittner, A. Claustrophobia in MRI: The role of cognitions. Magn. Reson. Imaging 2008, 26, 1081–1088. [Google Scholar] [CrossRef] [Green Version]
  21. Gulani, V.; Calamante, F.; Shellock, F.G.; Kanal, E.; Reeder, S.B. Gadolinium deposition in the brain: Summary of evidence and recommendations. Lancet. Neurol. 2017, 16, 564–570. [Google Scholar] [CrossRef]
  22. Kahn, J.; Posch, H.; Steffen, I.G.; Geisel, D.; Bauknecht, C.; Liebig, T.; Denecke, T. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients. Radiology 2017, 282, 708–716. [Google Scholar] [CrossRef] [PubMed]
  23. van der Molen, A.J.; Reimer, P.; Dekkers, I.A.; Bongartz, G.; Bellin, M.-F.; Bertolotto, M.; Clement, O.; Heinz-Peer, G.; Stacul, F.; Webb, J.A.W.; et al. Post-contrast acute kidney injury-Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur. Radiol. 2018, 28, 2845–2855. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Moos, S.I.; van Vemde, D.N.H.; Stoker, J.; Bipat, S. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: A meta-analysis. Eur. J. Radiol. 2013, 82, e387–e399. [Google Scholar] [CrossRef]
  25. Kooiman, J.; Pasha, S.M.; Zondag, W.; Sijpkens, Y.W.J.; van der Molen, A.J.; Huisman, M.V.; Dekkers, O.M. Meta-analysis: Serum creatinine changes following contrast enhanced CT imaging. Eur. J. Radiol. 2012, 81, 2554–2561. [Google Scholar] [CrossRef]
  26. Silverman, S.G.; Pedrosa, I.; Ellis, J.H.; Hindman, N.M.; Schieda, N.; Smith, A.D.; Remer, E.M.; Shinagare, A.B.; Curci, N.E.; Raman, S.S.; et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology 2019, 292, 475–488. [Google Scholar] [CrossRef] [Green Version]
  27. Rogosnitzky, M.; Branch, S. Gadolinium-based contrast agent toxicity: A review of known and proposed mechanisms. Biometals 2016, 29, 365–376. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Examples of images illustrating different image quality scores. Images illustrating image quality of four different contrast-enhanced ultrasound (CEUS) examinations performed with the same US system, convex probe, and standardized imaging protocol (gain, dynamic range) with bolus injection of 1.6 mL SonoVue (Bracco Imaging): (a,b) Low image quality of a cystic and solid renal lesion, score of 1 for focal image quality in case of (a) and score of 2 for (b). (c,d) High image quality of a small solid lesion with a size of 12 mm (c) and an exophytic lesion at the lower pole of the kidney (d), both assigned scores of 5 for focal lesion.
Figure 1. Examples of images illustrating different image quality scores. Images illustrating image quality of four different contrast-enhanced ultrasound (CEUS) examinations performed with the same US system, convex probe, and standardized imaging protocol (gain, dynamic range) with bolus injection of 1.6 mL SonoVue (Bracco Imaging): (a,b) Low image quality of a cystic and solid renal lesion, score of 1 for focal image quality in case of (a) and score of 2 for (b). (c,d) High image quality of a small solid lesion with a size of 12 mm (c) and an exophytic lesion at the lower pole of the kidney (d), both assigned scores of 5 for focal lesion.
Jcm 09 04081 g001
Figure 2. Distribution of continuous variables age, kidney depth, lesion depth and lesion size in focal and overall image quality classes. Boxplots of the distributions of the continuous variables across the five image quality classes (Likert scores) for focal image quality (ad) and overall image quality (eh). The results of the statistical tests are outlined in Table 2. (a,e) The age of the patient showed, neither for focal nor for overall image quality, a statistically significant relationship which could be visualized using boxplots.(b,f) The kidney depth showed for focal image quality, as well as overall image quality lower mean kidney depth for higher image quality.(c,g) The same relationship as described for kidney depth (b,f) applies for lesion depth and image quality. (d,h) The lesion size shows higher mean lesion size for higher focal image quality. For overall image quality, no tendency is visible.
Figure 2. Distribution of continuous variables age, kidney depth, lesion depth and lesion size in focal and overall image quality classes. Boxplots of the distributions of the continuous variables across the five image quality classes (Likert scores) for focal image quality (ad) and overall image quality (eh). The results of the statistical tests are outlined in Table 2. (a,e) The age of the patient showed, neither for focal nor for overall image quality, a statistically significant relationship which could be visualized using boxplots.(b,f) The kidney depth showed for focal image quality, as well as overall image quality lower mean kidney depth for higher image quality.(c,g) The same relationship as described for kidney depth (b,f) applies for lesion depth and image quality. (d,h) The lesion size shows higher mean lesion size for higher focal image quality. For overall image quality, no tendency is visible.
Jcm 09 04081 g002
Figure 3. ROC curves of the single parameters and the best combination.
Figure 3. ROC curves of the single parameters and the best combination.
Jcm 09 04081 g003
Table 1. Baseline characteristics of included patients.
Table 1. Baseline characteristics of included patients.
VariableValue
Characteristics of the patients
Age [years]62 (52–75)
Female sex43/143 (30.1%)
Characteristics of the kidney
Kidney depth [mm]48 (39–62)
Shrunken kidney37/143 (25.9%)
Reduced cortical thickness40/143 (28.0%)
Characteristics of the lesion
Cystic112/143 (78.3%)
Solid31/143 (21.7%)
Depth of renal lesion [mm]61 (46–74)
Largest lesion diameter [mm]20 (14–26)
Left side72/143 (50.3%)
Right side71/143 (49.7%)
Upper third45/143 (31.5%)
Middle third65/143 (45.5%)
Lower third33/143 (23.1%)
Exophytic lesion growth60/143 (42.0%)
Abbreviations: IQR denotes interquartile range.
Table 2. Influence of patient and lesion characteristics on focal and overall image quality.
Table 2. Influence of patient and lesion characteristics on focal and overall image quality.
VariableFocal QualityOverall Quality
Nonparametric testANOVANonparametric testANOVA
Age0.750 20.8090.387 20.460
Sex0.290 10.2960.426 10.434
Entity 30.433 10.4410.134 10.135
Reduced parenchymal thickness0.807 10.8140.275 10.280
Shrunken kidney<0.001 1<0.001<0.001 1<0.001
Kidney depth<0.001 2<0.001<0.001 2<0.001
Lesion depth<0.001 2<0.001<0.001 2<0.001
Lesion size0.006 20.0040.385 20.494
Exophytic lesion growth0.043 10.0420.021 10.020
Side0.321 10.3280.923 10.926
Intrarenal third0.064 10.0400.156 10.211
1 tested with the Chi2 test, 2 tested with Kruskal-Wallis test; 3 entity was stratified as cystic versus solid lesion; ANOVA denotes analysis of variance.
Table 3. ROC analysis to quantify effects of variables predicting high image quality.
Table 3. ROC analysis to quantify effects of variables predicting high image quality.
VariableFocal QualityOverall Quality
AUCAsymptotic significanceAsymptotic 95%-CIAUCAsymptotic significanceAsymptotic 95%-CI
Shrunken kidney0.684<0.0010.593–0.7760.748<0.0010.664–0.832
Kidney depth0.744<0.0010.661–0.8270.776<0.0010.696–0.856
Lesion depth0.800<0.0010.727–0.8730.695<0.0010.609–0.781
Lesion size0.6250.0110.534–0.715
Exophytic lesion growth0.6140.0200.521–0.7070.5020.0490.406–0.597
ROC denotes receiver operating characteristics, AUC denotes area under the curve, CI denotes confidence interval.
Table 4. ROC analysis of combined variables and their effect in predicting high (score of 4 or 5) focal image quality.
Table 4. ROC analysis of combined variables and their effect in predicting high (score of 4 or 5) focal image quality.
No.Combined VariablesROC Analysis
Shrunken kidneyKidney depthLesion depthLesion sizeExophytic lesion growthAUCAsymptotic significanceAsymptotic 95%-CI
1 XX 0.812<0.0010.741–0.883
2XXX 0.863<0.0010.805–0.921
3X X0.773<0.0010.697–0.850
4 XXX0.843<0.0010.777–0.909
5 XX 0.834<0.0010.767–0.902
6X XX 0.893<0.0010.841–0.945
7 XXXX0.851<0.0010.787–0.915
8XX XX0.870<0.0010.812–0.928
9X XXX0.910<0.0010.863–0.958
10XXXXX0.910<0.0010.863–0.957
11 XXX 0.842<0.0010.777–0.907
Since all variables were quantified regarding effect on high focal image quality (score of 4 or 5), eleven different combinations were investigated. With each of them, a bivariate logistic regression and ROC analysis were performed. Presented are the combinations, with ‘X’ indicating the single parameters to participate in the bivariate logistic regression and their AUC with asymptotic significance and 95%-CI. Combination No. 9 generates the largest AUC, while including one variable less than combination No. 10. ROC denotes receiver operating characteristics, AUC denotes area under the curve, CI denotes confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Spiesecke, P.; Fischer, T.; Friedersdorff, F.; Hamm, B.; Lerchbaumer, M.H. Quality Assessment of CEUS in Individuals with Small Renal Masses—Which Individual Factors Are Associated with High Image Quality? J. Clin. Med. 2020, 9, 4081. https://doi.org/10.3390/jcm9124081

AMA Style

Spiesecke P, Fischer T, Friedersdorff F, Hamm B, Lerchbaumer MH. Quality Assessment of CEUS in Individuals with Small Renal Masses—Which Individual Factors Are Associated with High Image Quality? Journal of Clinical Medicine. 2020; 9(12):4081. https://doi.org/10.3390/jcm9124081

Chicago/Turabian Style

Spiesecke, Paul, Thomas Fischer, Frank Friedersdorff, Bernd Hamm, and Markus Herbert Lerchbaumer. 2020. "Quality Assessment of CEUS in Individuals with Small Renal Masses—Which Individual Factors Are Associated with High Image Quality?" Journal of Clinical Medicine 9, no. 12: 4081. https://doi.org/10.3390/jcm9124081

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop